Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 2
2013 1
2015 9
2016 1
2017 3
2018 5
2019 3
2020 11
2021 11
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial.
Vajter J, Vachtenheim J Jr, Prikrylova Z, Berousek J, Vymazal T, Lischke R, Martin AK, Durila M. Vajter J, et al. Among authors: vymazal t. BMC Pulm Med. 2023 Mar 9;23(1):80. doi: 10.1186/s12890-023-02372-0. BMC Pulm Med. 2023. PMID: 36894877 Free PMC article. Clinical Trial.
COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT).
Musilová T, Jonáš J, Gombala T, David J, Fencl F, Klabusayová E, Klučka J, Kratochvíl M, Havránková P, Vrtková A, Slabá K, Tučková J, Homola L, Štourač P, Vymazal T. Musilová T, et al. Among authors: vymazal t. Children (Basel). 2023 Feb 10;10(2):348. doi: 10.3390/children10020348. Children (Basel). 2023. PMID: 36832477 Free PMC article.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Chastre J, François B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt CE, Sánchez-García M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Jafri HS; COMBACTE-MAGNET EVADE Study Group. Chastre J, et al. Crit Care. 2022 Nov 15;26(1):355. doi: 10.1186/s13054-022-04204-9. Crit Care. 2022. PMID: 36380312 Free PMC article. Clinical Trial.
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.
De Pascale G, Antonelli M, Deschepper M, Arvaniti K, Blot K, Brown BC, de Lange D, De Waele J, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovetsky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Blot S; Abdominal Sepsis Study (AbSeS) group and the Trials Group of the European Society of Intensive Care Medicine. De Pascale G, et al. Intensive Care Med. 2022 Nov;48(11):1593-1606. doi: 10.1007/s00134-022-06883-y. Epub 2022 Sep 23. Intensive Care Med. 2022. PMID: 36151335
Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin.
Šíma M, Bobek D, Cihlářová P, Ryšánek P, Roušarová J, Beroušek J, Kuchař M, Vymazal T, Slanař O. Šíma M, et al. Among authors: vymazal t. Pharmaceutics. 2022 Aug 4;14(8):1627. doi: 10.3390/pharmaceutics14081627. Pharmaceutics. 2022. PMID: 36015253 Free PMC article.
Association between use of enhanced recovery after surgery protocols and postoperative complications in colorectal surgery in Europe: The EuroPOWER international observational study.
Ripollés-Melchor J, Abad-Motos A, Cecconi M, Pearse R, Jaber S, Slim K, Francis N, Spinelli A, Joris J, Ioannidis O, Zarzava E, Şentürk NM, Koopman S, Goettel N, Stundner O, Vymazal T, Kocián P, El-Hussuna A, Pędziwiatr M, Gudaityte J, Latkauskas T, Santos MD, Machado H, Zahorec R, Cvetković A, Miric M, Georgiou M, Díez-Remesal Y, Jammer I, Mena GE, Zorrilla-Vaca A, Marino MV, Suárez-de-la-Rica A, García-Erce JA, Logroño-Ejea M, Ferrando-Ortolá C, De-Fuenmayor-Valera ML, Ugarte-Sierra B, de Andrés-Ibañez J, Abad-Gurumeta A, Pellino G, Gómez-Ríos MA, Poggioli G, Menzo-Wolthuis A, Castellano-Paulis B, Galán-Menéndez P, Aldecoa C, Ramírez-Rodríguez JM; EuroPOWER Study Investigators Group; Spanish Perioperative Audit and Research Network (RedGERM-SPARN); Francophone Group for Enhanced Recovery After Surgery (GRACE). Ripollés-Melchor J, et al. Among authors: vymazal t. J Clin Anesth. 2022 Sep;80:110752. doi: 10.1016/j.jclinane.2022.110752. Epub 2022 Apr 8. J Clin Anesth. 2022. PMID: 35405517
Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study.
Buhre W, de Korte-de Boer D, de Abreu MG, Scheeren T, Gruenewald M, Hoeft A, Spahn DR, Zarbock A, Daamen S, Westphal M, Brauer U, Dehnhardt T, Schmier S, Baron JF, De Hert S, Gavranović Ž, Cholley B, Vymazal T, Szczeklik W, Bornemann-Cimenti H, Soro Domingo MB, Grintescu I, Jankovic R, Belda J. Buhre W, et al. Among authors: vymazal t. Trials. 2022 Feb 22;23(1):168. doi: 10.1186/s13063-022-06058-6. Trials. 2022. PMID: 35193648 Free PMC article.
55 results